Targeting ferroptosis for treating kidney disease

Area of Science:

• Biochemistry
• Cell Biology
• Pathology

Background:

• Ferroptosis is a regulated cell death characterized by iron-dependent lipid peroxidation.
• Key regulatory pathways include the glutathione peroxidase 4 (GPX4) and FSP1-coenzyme Q10 pathways.
• Ferroptosis is implicated in various kidney diseases, including ischemia-reperfusion injury and nephrotoxin-induced damage.

Purpose of the Study:

• To review the role of ferroptosis in kidney disease.
• To discuss the potential of ferroptosis-targeting therapies for renal pathologies.
• To highlight considerations for therapeutic interventions involving cell death.

Main Methods:

• Literature review of ferroptosis research.
• Analysis of ferroptosis involvement in renal pathophysiology.
• Discussion of therapeutic strategies and challenges.

Main Results:

• Ferroptosis is a significant factor in multiple kidney injury models.
• Targeting ferroptosis presents a promising therapeutic avenue for kidney diseases.
• Careful consideration of cell type, death mode, and disease stage is crucial for therapeutic success.

Conclusions:

• Ferroptosis plays a critical role in the progression of kidney diseases.
• Developing clinically applicable ferroptosis-targeting drugs is a key future direction.
• Further investigation is needed to elucidate ferroptosis's precise role in human kidney disease.